{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:29:26Z","timestamp":1758274166114},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p> Limited information is available for guiding the management of upper urinary tract (UUT) urothelial carcinoma with squamous differentiation (UC-SqD). We did not even know about the difference between pure urothelial carcinoma (UC) and UC-SqD in the UUT regardless of treatment policy and prognosis. Instead of direct comparisons against each other, we included the third UUT malignancy, squamous cell carcinoma (SCC). This three-way-race model allows us to more clearly demonstrate the impact of squamous cell transformation on patient outcomes in UUT malignancy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively analysed 327 patients with UC, UC-SqD, or SCC who underwent radical nephroureterectomy with bladder cuff excision (RNU) at Taichung Veterans General Hospital, Taichung, Taiwan, between January 2006 and December 2013. A Kaplan\u2013Meier survival analysis was used to evaluate the relationship between patient outcomes and histology. Multivariate Cox proportional hazards modelling was also used to predict patient prognoses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The five-year postoperative cancer-specific survival (CSS) rates were 83.6% (UC), 74.4% (UC-SqD), and 55.6% (SCC), and the 5-year recurrence-free survival (RFS) rates were 87.7% (UC), 61.5% (UC-SqD), and 51.9% (SCC). UC patients had significantly better 5-year RFS than UC-SqD and SCC patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.001 and <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001, respectively). Patients with pure UC had significantly better 5-year CSS than SCC patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.0045). SCC or UC-SqD did not independently predict disease-specific mortality (HR 0.999, <jats:italic>p<\/jats:italic>\u2009=\u20090.999; HR 0.775, <jats:italic>p<\/jats:italic>\u2009=\u20090.632, respectively) or disease recurrence compared to pure UC (HR 2.934, <jats:italic>p<\/jats:italic>\u2009=\u20090.239; HR 1.422, <jats:italic>p<\/jats:italic>\u2009=\u20090.525, respectively). Age, lymphovascular invasion (LVI), and lymph node (LN) status independently predicted CSS, while pathological tumour stage, LN status, and LVI predicted RFS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>SCC and UC-SqD are not independent predictors of survival outcomes in patients with UUT tumours. However, they are associated with other worse prognostic factors. Hence, different treatments are needed for these two conditions, especially for SCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12010-5","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T15:02:59Z","timestamp":1708614179000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of squamous cell transformation on the prognosis of patients treated with radical nephroureterectomy"],"prefix":"10.1186","volume":"24","author":[{"given":"Li-Hua","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Shu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ri","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Yuan","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shian-Shiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Kuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Li","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Chuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"issue":"4","key":"12010_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.eururo.2010.12.042","volume":"59","author":"M Roupret","year":"2011","unstructured":"Roupret M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M, Oosterlinck W. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59(4):584\u201394.","journal-title":"Eur Urol"},{"issue":"2","key":"12010_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.juro.2012.04.009","volume":"188","author":"M Rink","year":"2012","unstructured":"Rink M, Robinson BD, Green DA, Cha EK, Hansen J, Comploj E, Margulis V, Raman JD, Ng CK, Remzi M, et al. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol. 2012;188(2):398\u2013404.","journal-title":"J Urol"},{"key":"12010_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4137\/CMO.S8103","volume":"6","author":"D Berz","year":"2012","unstructured":"Berz D, Rizack T, Weitzen S, Mega A, Renzulli J, Colvin G. Survival of patients with squamous cell malignancies of the upper urinary tract. Clin Med Insights Oncol. 2012;6:11\u20138.","journal-title":"Clin Med Insights Oncol"},{"issue":"3","key":"12010_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.urology.2005.09.010","volume":"67","author":"JE Busby","year":"2006","unstructured":"Busby JE, Brown GA, Tamboli P, Kamat AM, Dinney CP, Grossman HB, Matin SF. Upper urinary tract tumors with nontransitional histology: a single-center experience. Urology. 2006;67(3):518\u201323.","journal-title":"Urology"},{"issue":"1","key":"12010_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.juro.2007.03.033","volume":"178","author":"S Holmang","year":"2007","unstructured":"Holmang S, Lele SM, Johansson SL. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome. J Urol. 2007;178(1):51\u20136.","journal-title":"J Urol"},{"issue":"9","key":"12010_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107027","volume":"9","author":"YJ Lee","year":"2014","unstructured":"Lee YJ, Moon KC, Jeong CW, Kwak C, Kim HH, Ku JH. Impact of squamous and glandular differentiation on oncologic outcomes in upper and lower tract urothelial carcinoma. PLoS ONE. 2014;9(9): e107027.","journal-title":"PLoS ONE"},{"issue":"6","key":"12010_CR7","first-page":"7203","volume":"8","author":"N Makise","year":"2015","unstructured":"Makise N, Morikawa T, Kawai T, Nakagawa T, Kume H, Homma Y, Fukayama M. Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma. Int J Clin Exp Pathol. 2015;8(6):7203\u20139.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"12010_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.juro.2011.09.056","volume":"187","author":"B Ehdaie","year":"2012","unstructured":"Ehdaie B, Maschino A, Shariat SF, Rioja J, Hamilton RJ, Lowrance WT, Poon SA, Al-Ahmadie HA, Herr HW. Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. J Urol. 2012;187(1):74\u20139.","journal-title":"J Urol"},{"issue":"8","key":"12010_CR9","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.ejca.2013.02.001","volume":"49","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A, Green DA, Kluth LA, Pycha A, Fradet Y, et al. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Eur J Cancer. 2013;49(8):1889\u201397.","journal-title":"Eur J Cancer"},{"issue":"2","key":"12010_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.juro.2012.04.020","volume":"188","author":"SP Kim","year":"2012","unstructured":"Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, Boorjian SA. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. J Urol. 2012;188(2):405\u20139.","journal-title":"J Urol"},{"issue":"4","key":"12010_CR11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1464-410X.2011.10357.x","volume":"109","author":"F Abdollah","year":"2012","unstructured":"Abdollah F, Sun M, Jeldres C, Schmitges J, Thuret R, Djahangirian O, Tian Z, Shariat SF, Perrotte P, Montorsi F, et al. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis. BJU Int. 2012;109(4):564\u20139.","journal-title":"BJU Int"},{"issue":"4","key":"12010_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.urology.2008.11.042","volume":"73","author":"E Scosyrev","year":"2009","unstructured":"Scosyrev E, Yao J, Messing E. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? Urology. 2009;73(4):822\u20137.","journal-title":"Urology"},{"issue":"10","key":"12010_CR13","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.humpath.2013.04.005","volume":"44","author":"W Huang","year":"2013","unstructured":"Huang W, Williamson SR, Rao Q, Lopez-Beltran A, Montironi R, Eble JN, Grignon DJ, Idrees MT, Emerson RE, Zhou X, et al. Novel markers of squamous differentiation in the urinary bladder. Hum Pathol. 2013;44(10):1989\u201397.","journal-title":"Hum Pathol"},{"issue":"8","key":"12010_CR14","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.urolonc.2012.04.009","volume":"31","author":"RB Shah","year":"2013","unstructured":"Shah RB, Montgomery JS, Montie JE, Kunju LP. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital. Urologic Oncology. 2013;31(8):1650\u20135.","journal-title":"Urologic Oncology"},{"issue":"3","key":"12010_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/jcp.2006.038802","volume":"60","author":"A Lopez-Beltran","year":"2007","unstructured":"Lopez-Beltran A, Requena MJ, Alvarez-Kindelan J, Quintero A, Blanca A, Montironi R. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry. J Clin Pathol. 2007;60(3):332\u20135.","journal-title":"J Clin Pathol"},{"issue":"2","key":"12010_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.humpath.2012.05.018","volume":"44","author":"C Gulmann","year":"2013","unstructured":"Gulmann C, Paner GP, Parakh RS, Hansel DE, Shen SS, Ro JY, Annaiah C, Lopez-Beltran A, Rao P, Arora K, et al. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol. 2013;44(2):164\u201372.","journal-title":"Hum Pathol"},{"issue":"3","key":"12010_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12253-010-9343-x","volume":"17","author":"L Jankovic Velickovic","year":"2011","unstructured":"Jankovic Velickovic L, Dolicanin Z, Hattori T, Pesic I, Djordjevic B, Stojanovic M, Stankovic J, Visnic M, Stefanovic V. Divergent squamous differentiation in upper urothelial carcinoma-comparative clinicopathological and molecular study. Pathol Oncol Res. 2011;17(3):535\u20139.","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"12010_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00428-010-1017-2","volume":"458","author":"NT Gaisa","year":"2011","unstructured":"Gaisa NT, Braunschweig T, Reimer N, Bornemann J, Eltze E, Siegert S, Toma M, Villa L, Hartmann A, Knuechel R. Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer. Virchows Arch. 2011;458(3):301\u201312.","journal-title":"Virchows Arch"},{"issue":"12","key":"12010_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1136\/jcp.50.12.1032","volume":"50","author":"P Harnden","year":"1997","unstructured":"Harnden P, Southgate J. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas. J Clin Pathol. 1997;50(12):1032\u20133.","journal-title":"J Clin Pathol"},{"issue":"1","key":"12010_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00240-001-0232-3","volume":"30","author":"E Kunze","year":"2002","unstructured":"Kunze E, Francksen B. Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study. Urol Res. 2002;30(1):66\u201378.","journal-title":"Urol Res"},{"issue":"12","key":"12010_CR21","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/PAS.0b013e31805c9cd9","volume":"31","author":"N Lagwinski","year":"2007","unstructured":"Lagwinski N, Thomas A, Stephenson AJ, Campbell S, Hoschar AP, El-Gabry E, Dreicer R, Hansel DE. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol. 2007;31(12):1777\u201387.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"12010_CR22","first-page":"8143","volume":"8","author":"M Molitor","year":"2015","unstructured":"Molitor M, Junker K, Eltze E, Toma M, Denzinger S, Siegert S, Knuechel R, Gaisa NT. Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder. Int J Clin Exp Pathol. 2015;8(7):8143\u201358.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"12010_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1464-410X.2010.09900.x","volume":"108","author":"E Scosyrev","year":"2011","unstructured":"Scosyrev E, Ely BW, Messing EM, Speights VO, Grossman HB, Wood DP, de Vere White RW, Vogelzang NJ, Trump DL, Natale RB, et al. Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710). BJU Int. 2011;108(5):693\u20139.","journal-title":"BJU Int"},{"issue":"6","key":"12010_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129268","volume":"10","author":"MC Hsieh","year":"2015","unstructured":"Hsieh MC, Sung MT, Chiang PH, Huang CH, Tang Y, Su YL. The prognostic impact of histopathological variants in patients with Advanced Urothelial Carcinoma. PLoS ONE. 2015;10(6): e0129268.","journal-title":"PLoS ONE"},{"issue":"10","key":"12010_CR25","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1200\/JCO.1988.6.10.1590","volume":"6","author":"CJ Logothetis","year":"1988","unstructured":"Logothetis CJ, Johnson DE, Chong C, Dexeus FH, Sella A, Ogden S, Smith T, Swanson DA, Babaian RJ, Wishnow KI, et al. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. J Clin Oncol. 1988;6(10):1590\u20136.","journal-title":"J Clin Oncol"},{"issue":"2","key":"12010_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.clgc.2020.11.004","volume":"19","author":"M Deuker","year":"2021","unstructured":"Deuker M, Stolzenbach LF, Coll\u00e0 Ruvolo C, Nocera L, Tian Z, Roos FC, Becker A, Kluth LA, Tilki D, Shariat SF, et al. Upper urinary tract tumors: variant histology versus urothelial carcinoma. Clin Genitourin Cancer. 2021;19(2):117\u201324.","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"12010_CR27","first-page":"2241","volume":"38","author":"T Makino","year":"2018","unstructured":"Makino T, Izumi K, Natsagdorj A, Iwamoto H, Kadomoto S, Naito R, Kadono Y, Mizokami A. Significance of Perioperative Chemotherapy in squamous cell carcinoma of the Upper and lower urinary tract. Anticancer Res. 2018;38(4):2241\u20135.","journal-title":"Anticancer Res"},{"issue":"4","key":"12010_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","volume":"6","author":"N Lobo","year":"2020","unstructured":"Lobo N, Shariat SF, Guo CC, Fernandez MI, Kassouf W, Choudhury A, Gao J, Williams SB, Galsky MD, Taylor JA. What is the significance of variant histology in urothelial carcinoma? Eur Urol Focus. 2020;6(4):653\u201363.","journal-title":"Eur Urol Focus"},{"issue":"4","key":"12010_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.eururo.2019.10.026","volume":"77","author":"A Necchi","year":"2020","unstructured":"Necchi A, Raggi D, Gallina A, Madison R, Colecchia M, Lucian\u00f2 R, Montironi R, Giannatempo P, Far\u00e8 E, Pederzoli F, et al. Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies. Eur Urol. 2020;77(4):439\u201346.","journal-title":"Eur Urol"},{"issue":"1","key":"12010_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of tumours of the urinary system and male genital organs-Part B: prostate and bladder tumours. Eur Urol. 2016;70(1):106\u201319.","journal-title":"Eur Urol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12010-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T15:05:33Z","timestamp":1708614333000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12010-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12010"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12010-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"assertion":[{"value":"9 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board (reference number: CE21454B) of the Taichung Veterans General Hospital database, Taiwan. All procedures carried out in this study using human data were in accordance with the Declaration of Helsinki. The need for informed consent was waived by Institutional Review Board I and II of Taichung Veterans General Hospital owing to the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}